A pitfall of propidium iodide staining in fluorescence-activated cell sorting cell cycle analysis? [3]

Cancer Research

Volumn 67, Issue 11, 2007, Pages 5576-

  Buchegger, Franz ^a   Dupertuis, Yves Marc ^b   Perillo Adamer, Florence ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FLOXURIDINE; PROPIDIUM IODIDE; URACIL DNA GLYCOSIDASE;

CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL SELECTION; CELL STRAIN HT29; ENZYME DEGRADATION; FLUORESCENCE ANALYSIS; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

CELL CYCLE; CELL LINE, TUMOR; FLOW CYTOMETRY; FLOXURIDINE; HUMANS; PROPIDIUM; URACIL-DNA GLYCOSIDASE;

EID: 34347236553     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-3663     Document Type: Letter

References (5)

1. Fischer JA, Muller-Weeks S, Caradonna SJ. Fluorodeoxyuridine modulates cellular expression of the DNA base excision repair enzyme uracil-DNA glycosylase. Cancer Res 2006;66:8829-37.
2. Fischer JA, Muller-Weeks S, Caradonna S. Proteolytic degradation of the nuclear isoform of uracil-DNA glycosylase occurs during the S phase of the cell cycle. DNA Repair (Amst) 2004;3:505-13.
3. Dupertuis YM, Vazquez M, Mach JP, et al. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine. Cancer Res 2001;61:7971-7.
4. 125I-iododeoxyuridine. Eur J Nucl Med Mol Imaging 2006;33:613-20.
5. Miller EM, Kinsella TJ. Radiosensitization by fluorodeoxyuridine: effects of thymidylate synthase inhibition and cell synchronization. Cancer Res 1992;52: 1687-94.